NEW PRODUCT WATCH

RX PHARMACEUTICALSNEW INDICATIONRetrovir (zidovudine) from Burroughs Wellcome, Research Triangle Park, N.C., has been approved by the Food and Drug Administration to prevent HIV-infected pregnant women from transmitting the virus to their babies. Oral dose is one 100-mg capsule or 2 teaspoonfuls (10 mL) syrup every four hours (600 mg total daily dose) during pregnancy and continuous intravenous infusion

RX PHARMACEUTICALS

Register to view the full article